// App-Quantinova.ai

18026 : Pro-angiogenic Dual Gene Therapy in Chronic Diabetic Hindlimb Ischemia with Ultrasound Mediated Delivery of miR-126 and VEGF Plasmid DNA

Researchers

Presenter

  • Pratiek N Matkar

Principal Investigators

  • Hao H Chen

  • Yu J Kim

  • Dmitriy Rudenko

  • Michael Kuliszewski

  • Howard Leong-Poi

Medical Centers

  • St. Michael's Hosp, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Diabetes

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • MicroRNA 126

  • Vascular endothelial growth factor A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved